Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.54K Buy
+100
New +$9.6K ﹤0.01% 280
2025
Q3
Sell
-12,989
Closed -$1.56M 285
2025
Q2
$1.56M Buy
+12,989
New +$1.73M 0.59% 52
2025
Q1
Sell
-4
Closed -$650 95
2024
Q4
$650 Buy
+4
New +$654 ﹤0.01% 236

Other funds holding CLX

Stance Capital's CLX Position: Q2 2026 in Review

Stance Capital opened a new position in Clorox (CLX) in Q2 2026: 100 shares worth $9.54K. The stake represents ﹤0.01% of the portfolio and ranks #280 among its holdings. This is a return to the name: Stance Capital previously reported a position in CLX as recently as Q2 2025.

Stance Capital first reported a position in CLX in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.56M in Q2 2025. 1,048 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Stance Capital held 100 shares of Clorox worth $9.54K as of Q2 2026.
  • Clorox was a new Stance Capital position in Q2 2026.
  • Clorox made up ﹤0.01% of Stance Capital's portfolio in Q2 2026, its #280 holding.
  • Stance Capital first reported a position in Clorox in Q4 2024 and has held it in 3 quarters since.
  • Stance Capital's Clorox position peaked at $1.56M in Q2 2025.
  • 1,048 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.